Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dami Collier

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
British Journal of Hospital Medicine (London, England : 2005)|October 8, 2014
Traveller's molluscumDami Collier, Emma Wiley, Andrew Ward, et al.
Annals of African Medicine|June 14, 2014
Translation from research to clinical practice: fostering improved patient care through microscopicobservation drug susceptibility for tuberculosis diagnosis in NigeriaDami Collier, Ernest Ochang, Ibidunni Bode-Sojobi, et al.
International Journal of Mycobacteriology|January 21, 2016
Car windshield fragments as cheap alternative glass beads for homogenization of Mycobacterium tuberculosis cultures in a resource-limited settingErnest Afu Ochang, Dami Collier, Ibidunni Bode-Sojobi, et al.
The Journal of Antimicrobial Chemotherapy|July 13, 2016
Virological efficacy of PI monotherapy for HIV-1 in clinical practiceKate El Bouzidi, Dami Collier, Eleni Nastouli, et al.
Nigerian Journal of Medicine : Journal of the National Association of Resident Doctors of Nigeria|July 17, 2018
Feasibility and cost analysis of programmatic implementation of Microscopic-Observation Drug Susceptibility (MODS) assay in NigeriaErnest Afu Ochang, Oyinlola O Oduyebo, Ifeanyi A Onwuezobe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort AnalysisDami Collier, Collins Iwuji, Anne Derache, et al.
The Lancet. Infectious Diseases|March 27, 2019
Active and passive case-finding in tuberculosis-affected households in Peru: a 10-year prospective cohort studyMatthew J Saunders, Marco A Tovar, Dami Collier, et al.
HIV Medicine|February 26, 2022
Early HIV treatment and survival over six years of observation in the ANRS 12249 Treatment as Prevention TrialKathy Baisley, Joanna Orne-Gliemann, Joseph Larmarange, et al.
Cell Reports. Medicine|September 9, 2020
Combined Point-of-Care Nucleic Acid and Antibody Testing for SARS-CoV-2 following Emergence of D614G Spike VariantPetra Mlcochova, Dami Collier, Allyson Ritchie, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
British Journal of Hospital Medicine (London, England : 2005)|October 8, 2014
Traveller's molluscumDami Collier, Emma Wiley, Andrew Ward, et al.
Annals of African Medicine|June 14, 2014
Translation from research to clinical practice: fostering improved patient care through microscopicobservation drug susceptibility for tuberculosis diagnosis in NigeriaDami Collier, Ernest Ochang, Ibidunni Bode-Sojobi, et al.
International Journal of Mycobacteriology|January 21, 2016
Car windshield fragments as cheap alternative glass beads for homogenization of Mycobacterium tuberculosis cultures in a resource-limited settingErnest Afu Ochang, Dami Collier, Ibidunni Bode-Sojobi, et al.
The Journal of Antimicrobial Chemotherapy|July 13, 2016
Virological efficacy of PI monotherapy for HIV-1 in clinical practiceKate El Bouzidi, Dami Collier, Eleni Nastouli, et al.
Nigerian Journal of Medicine : Journal of the National Association of Resident Doctors of Nigeria|July 17, 2018
Feasibility and cost analysis of programmatic implementation of Microscopic-Observation Drug Susceptibility (MODS) assay in NigeriaErnest Afu Ochang, Oyinlola O Oduyebo, Ifeanyi A Onwuezobe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort AnalysisDami Collier, Collins Iwuji, Anne Derache, et al.
The Lancet. Infectious Diseases|March 27, 2019
Active and passive case-finding in tuberculosis-affected households in Peru: a 10-year prospective cohort studyMatthew J Saunders, Marco A Tovar, Dami Collier, et al.
HIV Medicine|February 26, 2022
Early HIV treatment and survival over six years of observation in the ANRS 12249 Treatment as Prevention TrialKathy Baisley, Joanna Orne-Gliemann, Joseph Larmarange, et al.
Cell Reports. Medicine|September 9, 2020
Combined Point-of-Care Nucleic Acid and Antibody Testing for SARS-CoV-2 following Emergence of D614G Spike VariantPetra Mlcochova, Dami Collier, Allyson Ritchie, et al.
Pageof 1